Welcome to our dedicated page for Walker & Dunlop SEC filings (Ticker: WD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Walker & Dunlop, Inc. (NYSE: WD) filings with the U.S. Securities and Exchange Commission, along with AI-powered tools that help interpret the information. Walker & Dunlop is a Maryland corporation whose common stock is listed on the New York Stock Exchange, and its SEC reports offer detail on its commercial real estate finance and advisory activities.
Among the filings available are Form 8-K current reports, which the company uses to disclose material events. Recent 8-Ks describe press releases reporting quarterly and year-to-date financial results, amendments to a Master Repurchase Agreement and related side letters with JPMorgan Chase Bank, N.A., changes to the board of directors, and performance-based equity awards for senior executives. These documents shed light on Walker & Dunlop’s capital structure, financing facilities, governance, and compensation practices.
Investors can also review filings that detail repurchase facilities used by Walker & Dunlop and its operating subsidiary, Walker & Dunlop, LLC. Amendments to these agreements adjust facility amounts, fees, and termination dates, illustrating how the company structures secured financing to support its commercial real estate activities.
On Stock Titan, AI-generated summaries highlight key points from lengthy filings, helping users quickly identify items such as new credit arrangements, changes in directorships, or disclosures about financial results. As additional forms such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and insider transaction reports on Form 4 are filed with the SEC, they can be incorporated into this page’s feed, with AI tools surfacing important terms, obligations, and governance details for easier review.
Walker & Dunlop is asking stockholders to vote at its 2026 annual meeting on May 19 in Denver on three main items: electing eight directors for one-year terms, ratifying KPMG LLP as independent auditor for 2026, and approving an advisory resolution on executive compensation.
The Board says seven of eight nominees are independent under NYSE rules and highlights a combined Chair/CEO role with an independent Lead Director. The proxy explains majority-vote standards for directors, how broker non-votes work, and that only holders of 34,311,069 common shares outstanding as of March 23, 2026 may vote.
The filing outlines the company’s long-term “Journey to ’30” strategy, following its prior “Drive to ’25” plan, targeting higher debt financing and property sales volumes, revenue growth, and earnings expansion. It also emphasizes pay‑for‑performance, noting below‑target 2025 cash bonuses and that recent performance‑based equity cycles paid nothing when goals were not met.
Governance and ESG sections describe NYSE‑compliant independent committees, board succession planning, human capital metrics like voluntary turnover of 7% in 2025, Great Place to Work survey results, and environmental initiatives including TCFD‑aligned climate reporting and emissions reduction efforts.
Walker William M reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. Chairman & CEO William M. Walker received a grant of 47.3310 dividend equivalent rights on Common Stock. Each right is the economic equivalent of one share of common stock and accrued on restricted stock units, vesting proportionately with those units. Following this award, Walker holds a total of 151.7764 dividend equivalent rights.
Walker & Dunlop EVP and General Counsel Daniel J. Groman received a grant of dividend equivalent rights tied to existing equity awards. On this Form 4, he acquired 115.601 dividend equivalent rights, each economically equal to one share of Walker & Dunlop common stock. These rights accrued on restricted stock units he already holds and will vest over time in step with those underlying restricted stock units. Following this grant, his directly held dividend equivalent rights total 285.146, reflecting routine, compensation-related adjustments rather than open-market trading.
Walker & Dunlop EVP and Chief HR Officer Paula A. Pryor received a routine equity-related award. On March 27, she acquired 48.740 dividend equivalent rights tied to existing restricted stock units, with each right economically equivalent to one share of common stock.
The dividend equivalent rights accrued on her restricted stock units and will vest proportionately with those units. Following this grant, she holds a total of 114.397 dividend equivalent rights, reflecting additional stock-based compensation rather than an open-market purchase or sale.
THEOBALD STEPHEN P reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. executive Stephen P. Theobald, EVP & Chief Operating Officer, received a grant of dividend equivalent rights tied to his existing equity awards. The award covers 142.566 dividend equivalent rights, each economically equivalent to one share of common stock.
These dividend equivalent rights accrued on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. Following this grant, he holds a total of 1,435.251 dividend equivalent rights directly.
Florkowski Gregory reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. executive vice president and chief financial officer Gregory Florkowski received a grant of 80.2100 Dividend Equivalent Rights on March 27, 2026. Each right is economically equivalent to one share of common stock and was credited in connection with restricted stock units he already holds.
Following this grant, Florkowski holds a total of 180.1480 dividend equivalent rights directly. These rights accrue as the company pays dividends and will vest on the same schedule and in the same proportions as the related restricted stock units.
Walker & Dunlop Inc: The Vanguard Group filed an amendment to its Schedule 13G reporting that, after an internal realignment, it beneficially owns 0 shares of Common Stock of Walker & Dunlop, Inc. The filing states certain subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538, and that The Vanguard Group, Inc. "no longer has, or is deemed to have, beneficial ownership" over those securities. The amendment is dated 03/27/2026 and references the realignment effective 01/12/2026.
Walker & Dunlop, Inc. director Dana L. Schmaltz purchased 1,000 shares of common stock in an open-market transaction at a price of $45.7800 per share. Following this buy, Schmaltz directly owns 84,325 shares of Walker & Dunlop common stock.
Walker & Dunlop director Dana L. Schmaltz exercised deferred stock units into common shares. On March 13, 2026, Schmaltz converted 1105 deferred stock units into 1105 shares of common stock at a stated price of $0.00 per share under the company’s Deferred Compensation Plan for Non-Employee Directors.
Following this compensation-related exercise, Schmaltz holds 83325 shares of Walker & Dunlop common stock directly. The deferred stock units were fully vested and represent one share of common stock each, and no shares were reported as sold in this filing.